Literature DB >> 24448921

Capturing disutility from waiting time.

Afschin Gandjour1.   

Abstract

Mesh:

Year:  2014        PMID: 24448921     DOI: 10.1007/s40273-014-0129-y

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  10 in total

1.  Preference based outcome measures for economic evaluation of drug interventions: quality adjusted life years (QALYs) versus healthy years equivalents (HYEs).

Authors:  A Mehrez; A Gafni
Journal:  Pharmacoeconomics       Date:  1992-05       Impact factor: 4.981

2.  Incorporating feelings related to the uncertainty about future health in utility measurement.

Authors:  Afschin Gandjour
Journal:  Health Econ       Date:  2008-10       Impact factor: 3.046

3.  The healthy-years equivalents: how to measure them using the standard gamble approach.

Authors:  A Mehrez; A Gafni
Journal:  Med Decis Making       Date:  1991 Apr-Jun       Impact factor: 2.583

Review 4.  Incorporating process utility into quality adjusted life years: a systematic review of empirical studies.

Authors:  Victoria K Brennan; Simon Dixon
Journal:  Pharmacoeconomics       Date:  2013-08       Impact factor: 4.981

5.  Healthy year equivalents versus quality-adjusted life years: the debate continues.

Authors:  Isabel Towers; Anne Spencer; John Brazier
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2005-06       Impact factor: 2.217

6.  Using conjoint analysis to estimate healthy-year equivalents for acute conditions: an application to vasomotor symptoms.

Authors:  F Reed Johnson; A Brett Hauber; Semra Ozdemir
Journal:  Value Health       Date:  2009 Jan-Feb       Impact factor: 5.725

7.  A bedside decision instrument to elicit a patient's preference concerning adjuvant chemotherapy for breast cancer.

Authors:  M N Levine; A Gafni; B Markham; D MacFarlane
Journal:  Ann Intern Med       Date:  1992-07-01       Impact factor: 25.391

8.  Quality-adjusted life years, utility theory, and healthy-years equivalents.

Authors:  A Mehrez; A Gafni
Journal:  Med Decis Making       Date:  1989 Apr-Jun       Impact factor: 2.583

9.  The ranking properties of healthy-years equivalents and quality-adjusted life-years under certainty and uncertainty.

Authors:  M Johannesson
Journal:  Int J Technol Assess Health Care       Date:  1995       Impact factor: 2.188

10.  HPV triage testing or repeat Pap smear for the management of atypical squamous cells (ASCUS) on Pap smear: is there evidence of process utility?

Authors:  Kirsten Howard; Glenn Salkeld; Kirsten McCaffery; Les Irwig
Journal:  Health Econ       Date:  2008-05       Impact factor: 3.046

  10 in total
  1 in total

Review 1.  Conceptualising 'Benefits Beyond Health' in the Context of the Quality-Adjusted Life-Year: A Critical Interpretive Synthesis.

Authors:  Lidia Engel; Stirling Bryan; David G T Whitehurst
Journal:  Pharmacoeconomics       Date:  2021-08-23       Impact factor: 4.981

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.